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Barcelona,		12	May	2017	
	
	
Dear	Prof.	Lee,	
We	 would	 like	 to	 submit	 our	 work	 titled	 “An	 automated	 optofluidic	 biosensor	
platform	combining	interferometric	sensors	and	injection	moulded	microfluidics”	to	
be	considered	for	publication	as	an	article	in	Lab-on-a-chip.		
This	 manuscript	 describes	 our	 recent	 work	 on	 an	 automated	 fluid	 handling	module	
designed	for	nanophotonic	biosensors.	This	work	describes	an	automated	on-chip	fluid	
handling	 module	 designed	 to	 meet	 the	 complex	 fluidic	 handling	 requirements	 of	
photonic	 biosensors,	 while	 maintaining	 compatibility	 with	 low-cost,	 practical	 and	
scalable	fabrication	techniques.	
As	 a	 proof-of-concept,	 the	 module	 is	 integrated	 with	 a	 Bimodal	 Waveguide	
Interferometric	biosensor,	and	automated	to	perform	a	competitive	immunoassay	for	
the	detection	of	the	antibiotic	Tetracycline.	
This	work	represents	a	major	advancement	 in	the	development	of	practical	photonic	
biosensors	 for	 real	 applications,	 and	 provides	 a	 facilitating	 platform	 that	 could	 pave	
the	way	 for	 automated	 point-of-care	 implementation	 for	 this	 specific	 type	 of	 highly	
sensitive	photonic	biosensor.	
Please	do	not	hesitate	to	contact	us,	if	you	require	any	further	information.	
Yours	sincerely,	
	
Prof.	Laura	M.	Lechuga	
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An	automated	optofluidic	biosensor	platform	combining	
interferometric	sensors	and	injection	moulded	microfluidics	
C.	Szydzika,	A.F.	Gavelab,	S.	Herranzb,	J.	Roccisanoa,	M.	Knoerzera,	P.	Thurgooda,	K.	Khoshmanesha,	
A.	Mitchella,	L.M.	Lechuga*b	
A	 primary	 limitation	 preventing	 practical	 implementation	 of	 photonic	 biosensors	within	 point-of-care	 platforms	 is	 their	
integration	with	fluidic	automation	subsystems.	For	most	diagnostic	applications,	photonic	biosensors	require	complex	fluid	
handling	protocols;	this	is	especially	prominent	in	the	case	of	competitive	immunoassays,	commonly	used	for	detection	of	
low-concentration,	low-molecular	weight	biomarkers.	For	this	reason,	complex	automated	microfluidic	systems	are	needed	
to	realise	the	full	point-of-care	potential	of	photonic	biosensors.	To	fulfil	this	requirement,	we	propose	an	on-chip	valve-
based	microfluidic	automation	module,	capable	of	automating	such	complex	fluid	handling.	This	module	is	realised	through	
application	of	a	PDMS	 injection	moulding	 fabrication	technique,	 recently	described	 in	our	previous	work,	which	enables	
practical	fabrication	of	normally	closed	pneumatically	actuated	elastomeric	valves.	In	this	work,	these	valves	are	configured	
to	achieve	multiplexed	reagent	addressing	for	an	on-chip	diaphragm	pump,	providing	the	sample	and	reagent	processing	
capabilities	required	for	automation	of	cyclic	competitive	immunoassays.	Application	of	this	technique	simplifies	fabrication	
and	introduces	the	potential	for	mass	production,	bringing	point-of-care	integration	of	complex	automated	microfluidics	
into	 the	 realm	of	practicality.	 This	module	 is	 integrated	with	a	highly	 sensitive,	 label-free	Bimodal	Waveguide	photonic	
biosensor,	and	is	demonstrated	in	the	context	of	a	proof-of-concept	biosensing	assay,	detecting	the	low-molecular	weight	
antibiotic	Tetracycline.	
Introduction	
Photonic	biosensors	enable	cost-effective,	highly	sensitive,	and	
selective	 label-free	 detection	 of	 target	 biomarkers	 1-3,	 they	
require	 relatively	 simple	 support	 equipment	 and	 software	 to	
operate	 and	 a	minimal	 physical	 footprint	 4.	With	 appropriate	
functionalisation	 strategies,	 these	 biosensors	 can	 be	 reused	
multiple	 times	 5	 and	 have	 been	 shown	 to	 be	 capable	 of	
exceedingly	 low	 limits	 of	 detection	 6,	 7	 While	 photonic	
biosensors	 are	 among	 the	 most	 highly	 sensitive	 biosensor	
technologies	 available	 2,	 many	 of	 their	 other	 unique	
characteristics	 are	 highly	 attractive	 for	 point-of-care	
applications,	 in	 which	 devices	 are	 generally	 required	 to	 be	
compact,	 self-sufficient	 and	 simple	 to	 operate	 while	
maintaining	 reliability,	 accuracy	 and	 reproducibility	 8.	 Despite	
these	advantages,	several	challenges	exist	 restricting	practical	
adoption	of	photonic	biosensors	for	point-of-care	devices1.	One	
of	the	most	significant	challenges	is	fluid	handling,	as	photonic	
biosensors	generally	require	complex	flow	handling	protocols,	
with	 sequential	 application	of	multiple	 reagents	 and	a	 critical	
need	 for	 fluidic	 isolation.	 Fluid	handling	becomes	 increasingly	
complex	 when	 advanced	 assays	 are	 required,	 such	 as	
competitive	immunoassays,	commonly	applied	when	the	target	
analyte	to	be	detected	is	of	low	molecular	weight	and	is	present	
in	very	low	concentrations,	as	is	the	case	with	pesticides,	toxins	
or	 antibiotic	 residues	 for	 food	 control	 and	 environmental	
monitoring	applications	9-11.	
The	field	of	microfluidics	has	been	proposed	extensively	as	
a	 solution	 for	 point-of-care	 diagnostic	 devices	 for	 the	
healthcare	 sector	 8,	 and	 has	 attracted	 significant	 interest	 in	
recent	 years	 12-15.	Microfluidic	 systems	 intended	 for	 point-of-
care	 application	 must	 employ	 simple,	 ideally	 automated	
operational	 principles,	 and	 must	 maintain	 compatibility	 with	
scalable	fabrication	techniques	suited	to	mass	fabrication	8,	13.	
As	 a	 result,	 few	 of	 the	 fluid	 handling	 strategies	 commonly	
employed	 in	 point-of-care	 devices	 are	 suited	 to	 the	 specific	
requirements	 of	 photonic	 biosensors,	 lacking	 the	 necessary	
dynamic	 functionality,	 fluid	 isolation	 performance	 and	
scalability.	Further,	although	integration	of	photonic	biosensors	
with	 complex	 automated	 microfluidic	 systems	 could	 provide	
the	 level	 of	 precise	 fluid	 handling	 required	 for	 point-of-care,	
merging	of	these	two	technologies	is	currently	challenging	due	
to	 fabrication	 complexity,	 and	 control	 of	 the	 interfaces	
necessary	for	the	fluid	handling	protocols	required	to	operate	
such	sensors.	
Numerous	 complex	 microfluidic	 fluid	 manipulation	
technologies	exist	in	the	literature	capable	of	achieving	on-chip	
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fluidic	 isolation.	 Digital	 microfluidics	 16,	 droplet	 based	
microfluidics	17	and	pneumatic	valve	based	microfluidic	systems	
18	 are	 some	 of	 the	 common	 technologies	 employed	 to	
manipulate,	 isolate	 and	mix	 precise	 volumes	 of	 fluid	 on-chip.	
Among	these	technologies,	pneumatic	valve	based	microfluidic	
systems	 demonstrate	 the	 highest	 potential	 for	 flexible	 and	
scalable	 integrated	 platforms.	 Microfluidic	 automation	 of	
exceedingly	complex	fluid	handling	protocols	has	been	achieved	
utilising	 pneumatic	 valve	 based	 systems	 for	 numerous	
applications	 18,	 including	 lab-on-a-chip	 platforms	 19-21,	 and	
biosensors	22,	23	.	Of	particular	interest,	this	technology	has	been	
applied	to	fluidic	automation	of	photonic	biosensors	24-26.	While	
application	 of	 such	 automated	 microfluidic	 systems	 provides	
the	required	fluidic	isolation,	a	high	degree	of	flexibility,	and	on-
chip	 fluidic	 control	 in	 a	 manner	 not	 otherwise	 possible,	
fabrication	 of	 the	 valves	 required	 to	 operate	 such	 devices	 is	
generally	cumbersome,	and	integration	can	become	difficult	to	
the	point	of	impracticality.			
We	 have	 recently	 begun	 to	 explore	 the	 possibility	 for	
complex	 integrated	microfluidics	and	 integrated	optics	 27.	We	
present	here	an	automated	fluid	handling	module	designed	for	
nanophotonic	 biosensors	 with	 complex	 valved	 microfluidics	
realised	 utilising	 a	 simple	 one-step	 injection	 moulding	
technique28,	 which	 can	 achieve	 complicated	 valved	
microfluidics	which	significantly	 reduce	 fabrication	complexity	
and	 have	 the	 potential	 for	 scale-up	 mass	 manufacture.	 We	
demonstrate	the	utility	of	this	microfluidic	by	integrating	it	with	
a	highly	sensitive	Bimodal	Waveguide	photonic	biosensor	4,	and	
demonstrate	 the	 functionality	 of	 the	 complete	 integrated	
system	 by	 performing	 repeated	 automated	 competitive	
immunoassays	 for	 the	 detection	 of	 an	 analyte	 of	 small	
molecular	 weight	 (the	 antibiotic	 tretacycline).	 The	 ability	 to	
realise	such	high	quality	valved	microfluidics	while	maintaining	
simplicity	 and	 scalability	 renders	 complex	 automated	
microfluidics	 of	 the	 sort	 required	 for	 photonic	 biosensors	
practical.	This	work	thus	represents	a	major	advancement	in	the	
development	of	practical	photonic	biosensors	for	point-of-care	
applications.	
Photonic	Background	
This	work	harnesses	the	bimodal	waveguide	photonic	biosensor	
4	 (BiMW)	depicted	 in	Fig.1,	 a	photonic	 interferometric	 sensor	
design	which	has	demonstrated	excellent	biosensing	capacities	
for	the	detection	of	diverse	biomarkers	29-31.		Operation	of	this	
sensor	 is	described	in	detail	 in	previous	publications	4,	but	for	
reference	 a	 brief	 description	 is	 provided	 here.	 In	 these	
biosensors,	 monochromatic	 visible	 light	 is	 coupled	 into	 the	
photonic	 chip	 through	 a	 single	 mode	 input	 waveguide	
(fundamental	 mode),	 this	 mode	 is	 then	 split	 between	 two	
guided	modes	(fundamental	and	the	first	order	mode),	with	the	
same	polarization,	through	an	interface	with	a	step	junction	in	
the	 waveguide	 geometry.	 The	 surface	 of	 the	 biosensor	 is	
passivated	with	 the	 exception	 of	 a	 sensing	 window,	 which	 is	
functionalised	 with	 a	 specific	 bioreceptor.	 Both	 modes	 are	
propagating	along	the	sensing	area	and	their	evanescent	fields	
interact	with	 the	biomolecules	at	 the	waveguide	 surface.	The	
evanescent	fundamental	mode	penetrates	less	deeply	into	the	
sensing	area,	and	can	thus	be	used	as	the	reference.	Any	change	
in	 the	 refractive	 index	 of	 the	 sensing	 area	 causes	 an	
interference	 pattern	 and	 in	 turn,	 a	 variation	 of	 the	 intensity	
distribution	 of	 the	 light	 exiting	 at	 the	 device	 output.	 By	
measuring	 the	 output	 light	 intensity	 distribution,	 the	 sensor	
response	can	be	determined.	
Fabrication	of	the	Bimodal	waveguide	photonic	biosensor	is	
achieved	in	a	cleanroom	facility	using	standard	microelectronics	
techniques	 as	 outlined	 in	 4,	 silicon	 nitride	 is	 used	 in	 the	
fabrication	 of	 visible	 wavelength	 waveguides,	 with	 a	 silicon	
dioxide	cladding	layer.	The	bimodal	waveguide	is	3	µm	in	width,	
has	a	rib	of	1.5	to	3	nm	and	a	thickness	of	150	nm	(single	mode	
zone)	and	340	nm	(bimodal	zone).	The	active	photonic	area	of	
the	 chip	 surface	 is	 limited	 to	 the	 photonic	 sensing	 window	
etched	 into	 the	 cladding	 within	 the	 bimodal	 segment	 of	 the	
waveguide,	with	an	area	of	15	mm	by	50	µm.	Multiple	devices	
are	 fabricated	at	wafer	 level,	and	 later	divided	 into	 individual	
chips	containing	20	BiMW	sensors	each,	separated	by	250	µm.	
Photonic	 access	 is	 achieved	 through	 end-fire	 coupling	 on	 the	
end	of	 the	device	while	output	 light	 is	 collected	with	a	multi-
channel	photodiode	or	CCD	camera	on	the	other	end.		
The	sensor	surface	is	functionalised	through	immobilisation	
of	 a	 specific	 target,	 and	 thus,	 the	 selective	 biomolecular	
recognition	 which	 takes	 place	 results	 in	 a	 change	 of	 the	
refractive	 index	 at	 the	 sensor	 surface,	 which	 perturbs	 the	
evanescent	field	and	can	thereby	be	detected	as	changes	in	the	
interferometer	output.				
Microfluidic	subsystem	integration	
Microfluidic	design	considerations	
As	described	above,	a	primary	issue	hindering	development	of	
point-of-care	 photonic	 biosensor	 platforms	 is	 practical	
integration	 with	 on-chip	 microfluidic	 systems,	 providing	
automated	 sample	 and	 reagent	 fluid	 handling	 1.	 Photonic	
biosensors	 generally	 require	 fairly	 complex	 fluid	 handling	
protocols,	 with	 multiple	 fluids	 manipulated	 sequentially;	 in	
addition,	fluidic	isolation	is	required	in	order	to	eliminate	cross	
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contamination	between	regents,	and	 flow	conditions	must	be	
reproducible.	Sample	volume	is	ideally	kept	to	a	minimum,	with	
channel	 geometry	minimised	 in	 order	 to	 ensure	 an	 adequate	
mass	 transport	 to	 the	 sensor	 surface	 to	 avoid	 unnecessary	
delays	in	the	biointeraction.	In	addition,	for	practical	point-of-
care	applications,	any	integrated	fluidic	system	must	be	cheap	
to	manufacture,	with	simple	interfaces	and	ideally	utilise	simple	
and	 scalable	 fabrication	 techniques	 compatible	 with	 mass	
production.			
Our	previous	work	has	primarily	utilised	simple	microfluidic	
systems	 fabricated	 using	 polydimethylsiloxane	 (PDMS)	 4,	 a	
biocompatible	 material	 commonly	 used	 in	 the	 fabrication	 of	
microfluidic	devices	32.	Fluidic	isolation	was	achieved	externally	
through	 manual	 valve	 manipulation,	 and	 samples	 were	
manually	introduced	to	a	sample	loop	and	flushed	through	the	
tubing	using	a	syringe	pump.		
	 While	numerous	on-chip	fluidic	actuation	technologies	exist	
in	 literature,	 valve	 based	 approaches	 are	 the	 best	 suited	 to	
providing	 fluidic	 isolation.	 Due	 to	 recent	 improvements	 in	
fabrication	 techniques	 28,	 it	 should	 be	 possible	 to	 adapt	
normally	 closed	 pneumatically	 driven	 on-chip	 valve	 based	
technologies	 23	 to	 realise	 a	 sufficiently	 complex,	 but	 reliable,	
valved	 microfluidic	 system	 to	 automate	 a	 photonic	 BiMW	
biosensor.	
Microfluidic	system	overview	
Fig	2	presents	a	diagram	of	the	fluid	handling	module	proposed	
for	 automatic	 operation	 of	 the	 BiMW	 sensor.	 Microfluidic	
channels	are	patterned	into	either	side	of	a	thin	PDMS	slab	seen	
in	Fig.2A,	utilising	an	injection	moulding	fabrication	technique.	
This	slab	is	bonded	with	a	thicker	PDMS	interface	slab,	biopsy	
punched	with	interfaces	and	reservoirs	of	appropriate	diameter	
as	seen	in	Fig.2B.	The	PDMS	chip	is	then	placed	over	the	BiMW	
sensor	and	its	associated	photonic	interface	and	thermal	stage,	
and	 clamped	 in	 place	 as	 outlined	 in	 4.	 	 The	module	 includes	
several	 gate	 valves	 to	 control	 the	 flow	 of	 the	 various	 fluids	
required	 for	 biosensing	 assays.	 These	 gate	 valves	 are	
multiplexed	 to	 minimise	 the	 number	 of	 external	 pneumatic	
actuators	required.		The	module	also	includes	a	single	on-chip	
diaphragm	pump	to	actuate	each	of	the	fluids	as	selected	by	the	
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gate	 valve	 assemblies.	 All	 fluidic	 channels	 patterned	 into	 the	
module	 are	 250µm	wide,	with	 exception	 of	 valve,	 pump	 and	
viaduct	 structures.	 The	 top	 channels,	 shown	as	green	 in	Fig.2	
are	160	µm	deep,	while	all	primary	fluidic	channels	patterned	
on	the	bottom	of	the	slab,	and	shown	in	blue,	are	140	µm	deep.	
6	on-chip	Fluidic	reservoirs,	accessible	through	routing	channels	
in	the	top	layer,	are	interfaced	through	500	µm	biopsy	punched	
viaducts	 from	 the	 top	 to	 bottom	 layer.	 Further	 detail	 on	
functional	sub-units	is	presented	below.	
Normally	closed	pneumatically	actuated	gate	valves	
The	 normally	 closed	 pneumatically	 actuated	 gate	 valves	 are	
illustrated	 in	 Fig	 2C.	 At	 the	 centre	 of	 each	 valve	 is	 a	 gate	
structure,	 a	barrier	of	PDMS,	400	µm	 long	and	100	µm	wide,	
these	gates	are	normally	lowered	to	close	channels,	and	can	be	
pneumatically	lifted	to	open	the	channel.	This	gate	is	patterned	
as	a	protrusion	on	a	thin	elastic	membrane	(60	-	100	µm	thick)	
which	can	be	deformed.	Above	this	membrane	is	an	oval	shaped	
open	channel	which	acts	as	an	actuation	chamber,	with	a	width	
of	 350	 µm,	 length	 of	 750	 µm	 and	 channel	 depth	 of	 160	 µm.	
When	 this	 chamber	 is	 evacuated,	 the	 elastomeric	 PDMS	
membrane	deforms	upward,	lifting	the	gate	from	the	bottom	of	
the	 channel,	 creating	 an	 opening	 in	 the	 barrier	 and	 allowing	
flow	across	the	valve	gate.	Positive	pressure	is	used	to	actively	
and	rapidly	close	the	valve	gates,	and	is	critical	to	enabling	rapid	
valve	 switching,	 required	 for	 efficient	 pumping.	 In	 order	 to	
actuate	and	automate	all	on-chip	valves,	a	customised	external	
support	equipment	and	software	package	was	developed.	This	
valve	 driver	 system	 operates	 on	 a	 similar	 principal	 to	 those	
shown	in	various	pneumatically	driven	on-chip	valve	systems	33	
The	 driver	 system	 interfaces	 with	 a	 control	 computer,	 and	
utilises	 micro-solenoid	 valves	 (Burkert	 Type	 6650-189292)	 to	
switch	 external	 pneumatic	 valves	 between	 two	 reservoirs,	
maintained	 at	 user	 defined	 pressure	 with	 an	 automated	
pressure	 regulation	 sub-system.	 A	 Python	 script	 is	 used	 to	
rapidly	 switch	 individual	 solenoid	 valves	 in	 sequences	
appropriate	to	operation	of	on-chip	control	components.	
Multiplexing	valve	assemblies		
Fluidic	 multiplexing	 is	 required	 to	 minimize	 the	 number	 of	
active	 valve	 control	 lines,	 and	 thereby	 to	 minimise	 external	
support	 equipment.	 It	 should	 be	 possible	 to	 achieve	
multiplexing,	 while	 reducing	 the	 chance	 of	 fluidic	
contamination	due	to	dead	volume	in	fluidic	junctions,	through	
minimisation	of	valve	size	and	by	optimising	valve	and	channel	
geometry.	 Multiplexing	 is	 achieved	 using	 parallel	 valve	
assemblies	 as	 shown	 in	 Fig.2C.	 These	 assemblies	 consist	 of	
three	 gate	 valves,	 controlling	 the	 flow	 through	 channels	 that	
connect	 with	 the	 on-chip	 fluid	 reservoirs.	 These	 valves	 are	
operated	symmetrically,	with	each	of	the	valves	paired	with	a	
complementary	valve	on	the	opposite	assembly.	Each	assembly	
is	 addressed	with	 its	 corresponding	 valve	 on	 the	 pump,	 such	
that	 only	 one	 of	 the	 open	 pairs	 is	 aspirated	 during	 pump	
actuation.	 These	 assemblies	 are	 designed	 with	 an	 elongated	
hexagonal	 geometry,	 with	 valve	 gates	 placed	 in	 a	 triangular	
configuration,	minimising	the	distance	between	valve	actuation	
chambers	 and	 minimising	 fluidic	 dead	 volume	 within	 the	
assembly.	Running	buffer	reservoirs	feed	into	the	central	gate,	
facilitating	washout	of	 the	assembly	when	switching	between	
reservoirs.		
On-chip	diaphragm	pump		
On-chip	fluid	propulsion	is	a	critical	function	required	to	achieve	
automation;	valve	based	on-chip	pump	systems	generally	utilise	
peristaltic	principles	 to	achieve	this	 34.	With	 the	availability	of	
the	 previously	 described	 gate	 valves,	 it	 is	 possible	 to	 also	
consider	 a	 pneumatically	 driven	 diaphragm	 pump	 for	 fluid	
actuation	 with	 active	 control	 of	 gate	 valves	 around	 this	
diaphragm,	 to	 control	 the	direction	of	 fluid	 flow.	 The	on-chip	
pump	 consists	 of	 a	 symmetrical	 chamber	 structure	 with	 two	
inlets,	two	outlets,	and	a	flexible	diaphragm,	illustrated	in	Fig.2C	
while	 utilisation	 of	 a	 dedicated	membrane,	 using	 an	 800	 µm	
square	 actuation	 chamber,	 provides	 propulsion.	 The	 desired	
inlet	is	initially	opened,	and	the	diaphragm	is	lifted,	increasing	
the	volume	of	 the	pump	chamber	and	drawing	 fluid	 from	the	
inlet;	the	inlet	is	then	closed,	the	desired	outlet	opened,	and	the	
diaphragm	is	forced	closed,	distending	into	the	pump	chamber	
and	reducing	its	volume,	forcing	the	contained	fluid	through	the	
open	outlet.		
Valve	assemblies	are	positioned	as	close	as	possible	to	the	
pump	 structure,	 so	 as	 to	 reduce	 fluidic	 volume	 of	 the	
connecting	 channel,	minimising	 required	 reagent	 volume	 and	
assay	 times.	 Due	 to	 the	 paired	 actuation	 of	 the	 valve	
assemblies,	 diffusion	 of	 fluids	 across	 open	 valve	 gates	 can	
contaminate	the	fluid	within	the	unused	assembly.	To	avoid	this	
and	 ensure	 pure	 sample	 or	 reagent	 delivery	 to	 the	 sensor	
surface,	it	is	necessary	to	purge	the	volume	of	the	assembly	to	
waste	when	switching	between	ports	on	opposite	assemblies.	
This,	as	well	as	priming	of	all	 fluidic	 lines,	 is	done	through	the	
waste	channel	output	of	the	pump.	
Microfluidic	Fabrication	
Fabrication	 of	 the	 microfluidic	 modules	 was	 accomplished	
utilising	a	combination	of	the	‘membrane	sandwich’	approach	
35,	and	a	novel	PDMS	Injection	moulding	technique,	previously	
described	 by	 our	 group	 28.	 In	 brief,	 complementary	 mould	
structures	 are	 fabricated	 using	 standard	 photolithography	
techniques	or	3D	printing.	All	fluidic	channel	structures	to	be	in	
contact	with	 the	 sensor	 surface	are	patterned	onto	a	bottom	
mould,	while	all	actuation	channels	and	via	or	interconnecting	
channels	 are	 patterned	 onto	 a	 complementary	 top	 mould.	
Polydimethylsiloxane	(PDMS)	pre-polymer	(Sylgard	184	Silicone	
Elastomer	 -	 Dow	 Corning)	 is	 mixed	 with	 curing	 agent	 with	 a	
weight	 ratio	 of	 10:1	 respectively,	 and	 thoroughly	 degassed	
under	 vacuum.	 Degassed	 Pre-Polymer	 composite	 is	 then	
introduced	between	aligned	complementary	mould	structures.	
The	assembled	mould	structure	is	then	placed	into	an	oven	for	
1	hour	at	80˚C,	when	cured,	the	mould	structures	are	separated	
and	the	PDMS	slab	(shown	in	Fig.	2A)	is	extracted.	A	blank	PDMS	
interface	slab	of	approximately	4-5	mm	thickness	is	then	biopsy	
punched	with	appropriately	aligned	pneumatic	interface	holes	
(0.75	 mm)	 and	 on-chip	 fluidic	 reservoirs	 (4-6	 mm).	 The	
actuation	side	of	the	injection	moulded	PDMS	slab	is	irreversibly	
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plasma	 bonded	 to	 the	 interface	 slab;	 this	 assembled	 PDMS	
module	 can	 then	 be	 aligned	 over	 the	 sensor	 surface	 of	 the	
BiMW	sensor	and	reversibly	bonded.	A	thin	(250-500	µm)	PDMS	
cap	can	then	be	placed	over	the	top	of	the	module,	this	 layer	
has	cut-outs	allowing	access	for	pneumatic	interface	tubing,	it	
is	reversibly	bonded	and	prevents	evaporation	of	fluid	from	the	
on-chip	reservoirs.	The	thin	evaporation	preventative	layer	can	
easily	be	 lifted	at	the	edge	of	the	assembly	to	allow	access	to	
the	on-chip	reservoirs;	small	perforations	can	be	made	with	a	
hypodermic	 needle	 in	 the	 areas	 centred	 on	 these	 reservoirs,	
these	perforations	will	seal	due	to	the	elastomeric	nature	of	the	
PDMS	 as	 long	 as	 the	 PDMS	 is	 flat,	 however	 they	 allow	 gas	
transfer	 when	 a	 pressure	 differential	 is	 applied,	 equilibrating	
pressure	within	the	reservoirs.	Finally,	the	assembled	module	is	
clamped	 using	 screws	 between	 a	 polymethyl	 methacrylate	
(PMMA)	 clamp	 layer	 and	 the	 BiMW	 setup	 outlined	 in	 4.	 The	
physically	realised	PDMS	device	is	presented	in	Fig.	3.	
Microfluidic	subsystem	characterisation	
To	verify	functionality	of	the	microfluidic	control	systems,	each	
of	the	components	was	initially	verified	independently.	Fig3A-B	
shows	these	subsystems	in	operation	with	food	dyes	verifying	
fluidic	 isolation,	 while	 the	 final	 integrated	 configuration	 is	
shown	 in	 Fig.3C.	 Low	 resolution	 microscopy	 of	 the	 entire	
module	in	operation	with	food	dyes	illustrates	the	functionality	
of	the	multiplexing	valve	assemblies	and	pump	in	Fig.3A,	where	
the	 running	 buffer	 is	 represented	 with	 yellow	 dye	 in	 central	
reservoirs,	while	 other	 colours	 represent	 reagent	 and	 sample	
fluids,	 respectively.	 Supplementary	 video-1	 demonstrates	
operation	of	the	on-chip	pump	with	food	dyes	purged	through	
the	 waste	 channel.	 Inset	 within	 Fig.3A	 includes	 higher	
resolution	 images	 of	 the	 pump	 and	 multiplexing	 assembly	
structures,	 as	 well	 as	 a	 cross-sectional	 cut	 of	 the	 pump	
structure,	 showing	 relative	 thickness	 of	 the	 valve	 structural	
layers.	 This	 dissected	 valve	 geometry	 is	 explored	 in	 further	
detail	 in	Supplementary	Fig.S-1.	Fig.3B	shows	 the	microfluidic	
module	aligned	and	reversibly	bonded	with	a	BiMW	sensor	chip,	
assessing	 valve	 functionality	 and	 verifying	 fluidic	 isolation.	 3C	
shows	 the	module	 integrated	 with	 an	 active	 BiMW	 photonic	
sensor	while	 in	 operation.	 The	 on-chip	 diaphragm	 pump	was	
experimentally	demonstrated	to	achieve	stable	flow	rates	up	to	
approximately	 7.5	 µL	 min-1.	 During	 Automated	 experimental	
protocols	flow	rates	of	1.5	µL	min-1	and	6	µL	min-1	were	used	for	
sample	flow	and	waste	purging	operations	respectively.	
Biosensing	proof-of-concept	
In	order	to	assess	the	functionality	of	the	microfluidic	module	
interfaced	 with	 the	 BiMW	 sensor,	 we	 have	 employed	 fluidic	
automation	in	the	context	of	a	complex	competitive	biosensing	
Fig.3.	Imaging	of	the	microfluidic	subsystems.,	Fig.3A	shows	a	low-resolution	microscopy	image	of	the	area	illustrated	in	Fig.2C	imaged	in	operation	with	color	dyes	while	bonded	
to	a	glass	slide.	Control	components	are	labeled,	with	high	resolution	images	of	the	multiplexing	valve	assembly	and	pump	inset	including	cross	sectional	cut	of	the	pump	structure.	
Fig.3B	shows	integration	of	the	microfluidic	module	with	the	BiMW	sensor,	with	channels	highlighted	with	color	dyes,	while	Fig.3C	shows	an	operational	 image	of	the	module	
integrated	with	an	active	BiMW	sensor.	
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assay	 requiring	 repetitive	 reference	 and	 competitive	 analysis	
cycles.		
As	a	proof-of-concept	we	demonstrate	the	detection	of	the	
antibiotic	 Tetracycline.	 Tetracycline	 is	one	of	 the	most	widely	
used	antibiotics,	 exhibiting	a	broad	 spectrum	of	 antimicrobial	
activity	 against	 a	 variety	 of	 disease-producing	 bacteria.	
Antibiotics	 are	 used	 extensively	 in	 human	 and	 veterinary	
medicine,	and	also	in	aquaculture,	in	order	to	prevent	or	treat	
microbial	infections.	Antibiotic	residues	from	different	sources	
(household,	 pharmaceutical	 industry,	 and	hospital)	 enter	 into	
municipal	 sewage	 but	 they	 are	 only	 partially	 eliminated	 at	
sewage	treatment	plants	and	as	consequence,	residues	of	these	
drugs	and	their	metabolites	are	released	into	the	environment.	
The	uncontrolled	exposure	to	antibiotic	residues	increases	the	
appearance	of	antibiotic-resistant	bacteria,	which	represents	a	
serious	and	growing	human	health	threat	worldwide,	because	
infections	from	resistant	bacteria	are	 increasingly	difficult	and	
expensive	 to	 treat.	 Therefore,	 due	 to	 its	 widespread	 use,	
monitoring	of	tetracycline	levels	is	important	in	numerous	fields	
such	 as	 clinical	 diagnosis36,	 food	 processing	 37,	 and	
environmental	pollutant	monitoring	 10.	Tetracycline	has	a	 low	
molecular	 weight	 (444.45)	 and	 is	 normally	 found	 in	 very	 low	
concentrations,	for	these	reasons	competitive	 immunoasssays	
are	well	suited	for	its	detection.	In	a	competitive	immunoassay	
format	the	chemical	target	to	be	detected,	present	in	a	sample,	
competes	 for	 the	 antibody	 binding	 sites	 with	 a	 receptor	
previously	 attached	 to	 the	 sensor	 surface.	 The	 sample	
containing	the	chemical	target	to	be	detected	is	incubated	for	a	
few	 minutes	 with	 a	 fixed	 quantity	 of	 the	 corresponding	
antibody	and	then	flowed	on	to	the	sensor	surface.	The	signal	is	
obtained	by	 the	 interaction	of	 the	 remaining	 free	antibody	of	
the	 incubated	 solution	 (sample+antibody)	 with	 the	 receptor	
layer.	 Therefore,	 the	 signal	 is	 inversely	 proportional	 to	 the	
concentration	 of	 the	 chemical	 target	 in	 the	 sample.	 The	
bioreceptor	 layer	 is	 expected	 to	 be	 re-usable	 during	 various	
analysis	 cycles	 by	 regeneration	 of	 the	 sensor	 surface,	 i.e.	 by	
dissociating	 the	 receptor-antibody	 interaction	 without	
destroying	the	bioreceptor	activity.		
It	should	be	possible	to	automate	our	developed	integrated	
microfluidic-BiMW	 system	 to	 perform	 the	 complex	 and	
repetitive	 fluid	handling	 required	 for	 the	competitive	assay	 in	
order	to	detect	the	presence	of	tetracycline.	Automation	of	this	
integrated	 system	 should	 allow	a	 significant	 increase	 in	 assay	
repeatability,	 while	 reducing	 manual	 labour	 as	 well	 as	 the	
influence	of	any	associated	manual	error	variables.	
In	 these	 experiments	 we	 have	 employed	 a	 tetracycline	
conjugate	 (DoxAc10-AD)	 and	 an	 antiserum	 specific	 for	 the	
family	of	tetracycline-related	antibiotics	(As256).	The	suitability	
of	 this	 immuno-reagents	 pair	 was	 first	 tested	 by	 a	 standard	
Surface	Plasmon	Resonance	(SPR)	Biosensor	(data	not	shown),	
achieving	a	LOD	of	0.09	nM	and	an	IC50	value	of	3.6	nM.	The	SPR	
sensor	could	be	reused	for	several	measure-regeneration	cycles	
of	tetracycline	by	using	10	mM	NaOH	solution	as	a	regeneration	
buffer.	
Surface	Biofunctionalisation	and	competitive	immunoassay	
A	previous	surface	biofunctionalisation	of	the	sensor	surface	is	
mandatory	 to	 perform	 the	 analysis.	 In	 this	 case	 we	 have	
employed	 a	 silanisation	 protocol	 with	 carboxyethylsilanetriol	
sodium	salt	(CTES)	which	provides	a	surface	functionalized	with	
carboxyl	groups,	allowing	the	further	covalent	immobilisation	of	
bioreceptors	presenting	amino	groups	 in	 their	 structure,	 such	
as	 the	 evaluated	 hapten-protein	 conjugate	 (DoxAc10-AD)	 by	
the	well-known	EDC/NHS	chemistry.	Briefly,	the	BiMW	sensors	
were	 first	 thoroughly	 cleaned,	 oxidised	 (oxygen	 plasma	
treatment,	 5	 min)	 and	 immersed	 in	 an	 aqueous	 0.5%	 CTES	
solution	 for	1	h. After	 that,	 the	CTES-treated	chips	were	rinse	
with	 deionised	 water,	 dried	 under	 nitrogen	 stream	 and	
thermally	cured	at	110°	C	for	1	h.	CTES	silanisation	is	performed	
utilising	 previously	 optimised	 protocols	 by	 our	 Group	 5.	 The	
silanised	chip	is	then	aligned	with	the	microfluidic	module	such	
that	 a	 BiMW	 sensing	 window	 is	 located	 within	 the	 sensor	
channel,	and	reversibly	bonded.	The	assembled	device	is	then	
placed	into	the	experimental	setup	and	connected	to	the	valve	
driver	 support	 equipment	 (for	 further	 information	 see:	
Supplementary	 Material	 SM-1:	 Experimental	 setup).	 Further	
surface	 functionalisation	 steps	 are	 performed	 utilising	 the	
automated	microfluidic	module,	at	a	flow	rate	of	1.5µL	min-1,	
an	automated	on-chip	fluid	handling	protocol	is	executed	with	
minimal	user	input,	thereby	reducing	user	introduced	variability	
and	resulting	 in	more	reproducible	surface	conditions.	Due	to	
the	 reactive	 and	 time	 critical	 nature	 of	 functionalisation	
reagents,	 it	 is	 necessary	 to	 prepare	 and	 load	 reagents	
sequentially	into	on-chip	reservoirs	as	they	are	required.	MilliQ	
DI	water	is	used	as	a	running	buffer	for	the	following	process:	
initially,	 the	 reactive	 carboxylic	 groups	of	 the	 silanised	 sensor	
surface	are	activated	by	flowing	200	mM	EDC/	50	mM	sulfo-NHS	
solution	in	100	mM	MES	buffer	containing	0.5	M	NaCl,	at	pH	5.0	
for	 10	minutes.	 The	 surface	 is	 briefly	 cleansed	with	DI	water,	
followed	by	 flow	of	 the	 receptor	molecule	 (DoxAc10-AD)	at	a	
concentration	of	20	µg/mL	in	SA	buffer	(pH	5)	allowing	bonding	
with	the	freshly	activated	surface	for	15	minutes.	An	additional	
DI	water	rinse	 is	 followed	by	a	 final	 flow	of	Ethanolamine	1M	
(pH	8.5),	to	deactivate	residual	carboxylic	groups	and	to	remove	
electrostatically	bound	ligand	in	an	effort	to	avoid	non-specific	
adsorptions.At	this	stage	the	sensor	assembly	 is	 ready	for	the	
competitive	 assay.	 In	 a	 competitive	 immunoassay	 different	
steps	 are	 involved.	 Initially,	 the	 sensor	 surface	 needs	 to	 be	
conditioned	 with	 a	 buffer	 solution,	 until	 reaching	 a	 stable	
baseline	 signal.	 Then,	 the	 sample	 is	 mixed	 with	 a	 constant	
concentration	of	the	antibody	and	the	mixture	is	injected	onto	
the	 sensor	 surface,	allowing	 the	 interaction	between	 the	 free	
antibody	and	 the	 receptor	 immobilised	onto	 the	 surface.	 The	
sensor	 surface	 is	 then	 washed	 with	 buffer	 to	 remove	 all	
unbound	material	and	the	signal	after	stabilisation	is	evaluated.	
Finally,	 the	surface	 is	regenerated	and	conditioned	again	with	
buffer,	starting	a	new	measurement	cycle.	
The	surface	functionalisation	protocol	and	the	competitive	
immunoassay	employed	are	briefly	introduced	in	Fig.4.	Fig.	4A	
illustrates	 the	sensor	surface	 in	 its	 initial	 state,	4B-D	 illustrate	
the	 technique	used	 to	 immobilise	 the	 receptor	 (
.	 Fig.4E	 illustrates	 a	 functionalised	 surface	 in	
which	the	receptor	molecule	has	captured	the	specific	antibody;	
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following	 this	 Fig.4F.	 shows	 the	 target-antibody	 interactions	
blocking	antibodies	from	surface	interaction.	
Automated	assay	protocol	
In	order	to	perform	a	competitive	immunoassay,	the	automated	
system	must	 be	 able	 to	 perform	 an	 initial	 reference	 assay	 in	
order	 to	 benchmark	 sensor	 response	 to	 a	 known	 antibody	
concentration,	 followed	 by	 a	 competitive	 assay	which	will	 be	
used	 to	 quantify	 the	 target	 concentration.	 This	 ‘cycle’	 of	
reference	and	competitive	assays	are	complementary	and	must	
be	repeated	for	each	competitive	assay.	Each	assay	requires	an	
initial	 flow	 of	 buffer	 solution	 in	 order	 to	 achieve	 a	 sensor	
baseline;	 this	 is	 followed	 by	 a	 sample	 flow,	 allowing	 surface	
interaction,	likewise	followed	by	a	secondary	flow	of	buffer	as	a	
sample	 washout	 step.	 The	 secondary	 baseline	 attained	 at	
washout	can	then	be	compared	with	initial	baseline	magnitude	
to	interpret	the	effect	of	surface	interaction.	The	sensor	surface	
finally	 requires	 regeneration	 by	 actively	 stripping	 the	 bound	
antibodies	 using	 a	 mild	 acid	 or	 basic	 conditions,	 and	 a	 final	
buffer	 flow	applied	to	bring	the	system	back	to	a	ready	state.	
Automation	 of	 these	 assay	 protocols,	 implemented	 using	 the	
microfluidic	 module	 developed	 in	 this	 work,	 should	 result	 in	
time	 consistent	 cycling	 of	 the	 required	 steps	 of	 the	 complex	
assay,	 reducing	 interaction	 time	 variability	 and	 ensuring	 pure	
sample	and	reagent	delivery.	In	order	to	achieve	this,	20-minute	
detection	 cycles	 are	 programmed	 using	 Python	 script,	
automating	all	fluid	handling	required	to	perform	an	assay	and	
subsequent	surface	regeneration	using	the	BiMW	sensor,	with	
the	 exception	 of	 sample	 preparation.	 Initially	 running	 buffer,	
Phosphate	buffered	saline	(PBS)	and	regeneration	fluid	(NaOH-
10mM),	are	 loaded	into	the	on-chip	reservoirs.	An	automated	
protocol	 then	primes	 these	 channels,	 sending	a	 small	 volume	
through	the	waste	outlet,	ensuring	any	bubbles	are	purged	from	
the	system	and	ensuring	 reagents	are	 ready	at	 the	valve	gate	
when	required.	Following	initial	priming,	sample	can	be	loaded	
and	 the	 automated	 sequence	 initiated,	 this	 sequence	 will	
initially	 flush	 sample	 through	 the	 waste	 path,	 cleansing	 the	
system	 and	 ensuring	 that	 sample	 delivered	 to	 the	 sensor	 is	
bubble	 and	 contaminant	 free;	 the	 sample	 is	 then	 directed	
through	 the	 sensor	 channel	 for	 10	 minutes	 passing	 a	 total	
sample	 volume	 of	 approximately	 15µL,	 during	 which	 time	
specific	 target	 binding	 can	 occur.	 Following	 this	 surface	
interaction	period,	the	system	flows	PBS	over	the	sensor	for	4	
minutes	 to	 flush	 out	 any	 unbound	 sample	 and	 to	 obtain	 a	
secondary	baseline,	this	is	followed	by	a	3-minute	regeneration	
cycle	where	NaOH	is	directed	over	the	sensor	surface,	stripping	
bound	 antibodies	 and	 readying	 the	 system	 for	 subsequent	
detection	cycles;	finally,	the	sensor	surface	is	washed	out	with	
PBS	for	an	additional	3	minutes	returning	the	system	to	a	ready	
state	for	subsequent	measurements.	
This	automated	protocol	performs	the	assay	fluid	handling	
consistently,	 ensuring	 that	 flow	 conditions	 and	 interaction	
times	 are	 consistent	 for	 each	 assay.	 This	was	 initially	 verified	
through	manipulation	 of	 colour	 food	 dyes	 in	 place	 of	 sample	
and	 reagent	 fluids,	 as	 shown	 in	 Fig.3C,	 prior	 to	 the	 assay	
application.	
Biosensing	of	tetracycline	antibiotic	
Application	of	 the	 automated	assay	protocol	 to	perform	 fluid	
handling	 required	 for	 the	 competitive	 assay	 should	 allow	
repeated	reproducible	assay	cycles,	allowing	target	biomarker	
quantification,	 and	 evaluation	 of	 surface	 chemistry	 and	 its	
Fig.4.	Conceptually	illustrated	surface	conditions	during	surface	biofunctionalisation	and	during	a	competitive	assay.	Fig.4A	shows	a	clean	sensor	surface	prior	to	
functionalisation,	this	image	represents	a	cross	section	of	the	BiMW,	showing	the	waveguide	surface	(foreground)	at	the	sensor	window	area	with	the	passivation	
layer	seen	in	green.	Fig.4B	illustrates	the	sensor	surface	post	silanisation	with	CTES,	C	illustrates	receptor	binding,	followed	by	ethanolamine	treatment	in	D,	blocking	
any	unbound	carboxylic	groups.	Fig.4E	illustrates	surface	interactions	during	a	reference	assay,	with	antibodies	binding	to	the	receptor	molecules,	while	F	illustrates	
a	competitive	assay,	antibody	binding	sites	are	occupied	by	target	molecules	reducing	overall	surface	interaction.	
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effectiveness	 following	 multiple	 regeneration	 cycles.	 Prior	 to	
experimentation,	 the	 sensor	 was	 initially	 biofunctionalised,	
reagents	 loaded	 into	 on-chip	 reservoirs	 and	 channels	 primed	
using	an	automated	priming	protocol.	Then,	the	response	of	the	
sensor	was	evaluated	by	using	the	automated	assay	protocol.	
	 As	proof	of	concept,	two	different	samples	were	analysed:	
PBS	(sample	free	of	antibiotic,	used	as	a	reference	sample)	and	
a	2	nM	tetracycline	solution	in	PBS.	First,	the	sample	was	mixed	
with	the	antibody	(AS-256)	to	a	final	concentration	of	1	µg/mL.	
Then,	15	µL	of	 the	 sample-antibody	mixture	was	passed	over	
the	sensor	over	10	minutes.	During	this	step,	the	free	antibodies	
interact	with	the	receptor	immobilized	onto	the	sensor	surface.	
It	is	expected	that	the	presence	of	tetracycline	in	the	sample	will	
result	 in	 a	 lower	 interaction	 signal	 than	 the	 reference	
(competitive	 assay).	 During	 these	 experiments,	 the	 reference	
assay	 (sample	 free	 of	 tetracycline)	was	 repeated	 before	 each	
competitive	assay	(2	nM	tetracycline	sample),	in	an	attempt	to	
compensate	for	degradation	of	the	sensor	surface	occurring	as	
a	result	of	repeated	surface	regeneration.	
	 Fig.5	 shows	 the	 sensor	 response	 for	 a	 sample	 free	 of	
tetracycline	 (reference	 assay)	 and	 a	 sample	 containing	
tetracycline	 in	 a	 concentration	 of	 2	 nM	 (competitive	 assay),	
sequentially	analysed.	Fig.5A	shows	sensor	readings	during	an	
example	 20-minute	 automated	measurement	 cycle	 running	 a	
target-free	 reference	 sample,	 with	 inset	 (1-4)	 conceptually	
illustrating	 interactions	occurring	on	the	surface	of	the	sensor	
at	various	times	during	the	cycle.	The	reference	sample	is	mixed	
with	the	antibody	and	pipetted	 into	the	appropriate	reservoir	
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and	 the	 automated	 detection	 cycle	 is	 initiated.	 Fig.5B	 (1-4)	
highlights	 the	 fluidic	path	 taken	 from	associated	 reservoirs	 at	
time	points	corresponding	to	5A	and	5C.	 Initially	the	sensor	 is	
immersed	in	PBS	at	a	constant	flow-rate	of	1.5	µL	min-1;	this	is	
allowed	to	form	a	stable	baseline,	(1)	before	introduction	of	the	
sample.	 Initially,	 introduction	 of	 the	 sample	 causes	 a	 sharp	
change	in	signal	due	to	a	bulk	change	in	the	refractive	index	of	
the	spiked	sample,	this	is	followed	by	a	fixed	surface	interaction	
period	 in	which	 antibodies	 present	 in	 the	 sample	bind	 to	 the	
immobilised	 receptor,	 gradually	modifying	 refractive	 index	 at	
the	sensor	surface,	which	can	be	seen	as	a	gradual	change	in	the	
signal	and	is	conceptually	illustrated	in	(2).	Sample	washout	can	
be	seen	as	a	sharp	change,	corresponding	in	magnitude	to	that	
observed	at	sample	inflow,	this	is	due	to	the	refractive	index	of	
the	fluid	returning	to	that	of	the	running	buffer	or	PBS,	forming	
a	 secondary	 baseline,	 shown	 conceptually	 in	 (3).	 Finally,	 the	
surface	 of	 the	 sensor	 is	 stripped	 of	 bound	 antibodies	 using	 a	
regeneration	solution	(NaOH,10mM),	this	surface	regeneration	
step	(4)	prepares	the	sensor	surface	for	subsequent	detection	
cycles,	following	a	return	to	running	buffer	(PBS)	and	a	return	
to	the	initial	baseline	(1)	
	 Surface	 interactions	are	quantified	by	assessing	 the	phase	
variation	of	the	BiMW	interferometer,	taking	into	account	that	
a	complete	oscillation	or	fringe	corresponds	to	a	2π	rad	phase	
variation.	The	arbitrary	sensor	signal	(%)	value,	shown	in	Fig.5A	
and	C	is	tracked	from	the	initial	baseline	time	point	in	5A(1)	to	
the	 secondary	 baseline	 at	 time	 point	 5A(3),	 taking	 any	
transitions	 across	 the	 fringe	 into	 account	 and	 subtracting	 the	
bulk	 refractive	 index	 peak.	 The	 total	 distance	 travelled	
represents	the	magnitude	of	the	surface	interaction	signal,	and	
are	shown	relative	to	π	inset	in	Fig.5A	and	C	
Fig.5C	 displays	 sensor	 readings	 obtained	 during	 a	
competitive	 assay	 performed	 immediately	 following	 the	
reference,	 along	 with	 corresponding	 conceptual	
representations	of	surface	interactions	in	insets	of	Fig.5C(1-4).	
The	competitive	assay	is	performed	using	the	same	automated	
protocol	 as	 the	 reference;	 however	 the	 introduced	 sample	
contains	2	nM	of	Tetracycline.	It	can	be	noted	that	the	resultant	
increase	in	bulk	refractive	index	due	to	additional	components	
present	in	the	sample	has	increased	the	magnitude	of	the	spike	
observed	at	 sample	 introduction	and	washout.	 It	 can	be	seen	
that	the	gradient	of	the	surface	interaction	shown	in	area	(2),	is	
reduced	when	compared	with	the	reference	sample.	 It	 is	also	
clear	 that	 the	 sensor	 response	 (overall	 magnitude	 of	 surface	
interaction,	 inset	 in	 5A	 and	 C)	 is	 reduced	 in	 the	 competitive	
assay	due	to	the	presence	of	the	target	molecules	(tetracycline)	
in	 the	 sample,	 occupying	 the	 binding	 sites	 of	 the	 antibody,	
thereby	reducing	the	quantity	of	available	antibodies	capable	of	
binding	 to	 the	 receptor	 in	 the	 surface	 by	 an	 amount	
proportional	 to	 the	 target	 concentration.	 Fig.6A	 overlays	 the	
response	of	a	2	nM	tetracycline	sample	(competitive	assay)	and	
its	corresponding	reference.	As	it	can	be	seen,	the	presence	of	
2	 nM	 tetracycline	 leads	 to	 sensor	 response	 of	 0.13	 π	 rad	
comparing	 to	 0.28	 π	 rad	 for	 a	 sample	 free	 of	 antibiotic	
(reference),	 i.e.	 the	 presence	 of	 tetracycline	 lead	 to	 a	 54%	
inhibition	 of	 the	 sensor	 response.	 The	 response	 of	 the	
competitive	 assay	 can	 be	 expressed	 as	 a	 percentage	 of	 its	
corresponding	 reference	 assay,	 this	 is	 shown	 in	 the	 inset	 in	
Fig.6A,	which	corresponds	to	cycle	2	in	Fig.6B.		
In	 order	 to	 assess	 the	 stability	 of	 the	 proof-of-concept	
surface	functionalisation,	repetitive	reference	and	competitive	
cycles	 were	 performed,	 with	 target	 and	 antibody	
concentrations	 maintained	 at	 constant	 levels	 for	 each	
repetition.	Fig.6B	 illustrates	 the	 results,	with	 reference	 cycles	
shown	 in	 green	 and	 competitive	 assays	 shown	 in	 red.	 Raw	
sensor	data	for	each	assay	is	shown	in	Supplementary	Fig.S-2.	
As	 can	 be	 observed	 in	 figure	 6B,	 the	 sensor	 response	 to	
reference	assays	in	subsequent	pairs	reduces	significantly.	This	
is	 most	 noticeable	 between	 the	 first	 two	 assay	 pairs,	 and	 is	
presumably	 due	 to	 degradation	 of	 the	 immobilized	 receptor	
during	the	regeneration	step.	As	the	presence	of	target	analyte	
is	detected	as	response	inhibition,	this	sensor	degradation	can	
introduce	 a	 false	 positive	 result.	 For	 this	 reason,	 In	 order	 to	
dynamically	compensate	for	surface	degradation	and	 increase	
the	 lifetime	 of	 the	 biosensor,	 each	 competitive	 assay	 was	
directly	preceded	by	a	reference	assay.	this	could	be	avoided	in	
future	work	by	optimizing	the	sensor	surface	functionalisation	
procedure	 (receptor	 immobilization)	 and	 regeneration	 step.	
Each	 assay	 pair	 was	 normalized	 through	 comparison	 of	 the	
competitive	 result	 with	 its	 corresponding	 reference	 as	 a	
percentage,	and	the	competitive	signal	in	%	shown	in	Fig.6C.			
It	 can	be	observed	 that	 the	 response	of	 the	 sensor	 to	 the	
presence	 of	 tetracycline	 is	 comparatively	 stable,	 with	 signals	
(sample/reference	 ratio)	at	between	40–50	%	 for	 the	 initial	4	
assay	pairs,	this	indicates	relative	surface	stability	for	at	least	8	
measurement-regeneration	 cycles.	 After	 8	 analysis	 a	 clear	
sensor	degradation	is	observed,	due	to	the	repeated	exposure	
of	the	bioreceptors	to	the	regeneration	solution	(basic	media).	
The	increase	in	the	competitive	signal	is	presumably	due	to	the	
increase	 in	 non-specific	 binding	 events	 occurring	 as	 surface	
degradation	results	in	the	biolayer	becoming	less	specific.	This	
biolayer	 lifetime	 is	 consistent	 with	 our	 previous	 results	 30,	
however	 it	 is	 presumable	 that	 improvements	 to	 the	 surface	
functionalisation	 protocol	 used	 in	 this	 proof-of-concept	 work	
could	significantly	improve	surface	integrity.		
Conclusion	
This	work	demonstrates	a	proof-of-concept	implementation	of	
an	automated	 fluid	handling	module	 for	photonic	biosensors.	
The	module	is	fabricated	utilising	a	one-step	injection	moulding	
technique	which	significantly	reduces	fabrication	complexity	of	
normally	closed	on-chip	elastomer	valves.	This	work	makes	use	
f	 the	 fabrication	 technique	 to	 realise	 on-chip	 fluid	 handling	
architecture	required	for	operation	of	a	highly	sensitive	bimodal	
waveguide	 photonic	 biosensor,	 automating	 complex	 fluid	
handling	protocols	required	for	the	operation	of	a	competitive	
immunoassay.	
The	capacity	of	the	automated	system	is	demonstrated	in	a	
proof	of	concept	competitive	immunoassay	for	the	detection	of	
the	 common	 antibiotic	 Tetracycline.	 The	 system	 is	 shown	 to	
perform	 repetitive	 automated	 assay	 cycles,	 allowing	 a	 high	
degree	 of	 experimental	 control	 and	 temporal	 resolution.	 The	
system	demonstrates	multiple	reference	and	competitive	assay	
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cycles,	 regenerating	 the	 sensor	 bioreceptor	 later	 between	
assays,	 as	 would	 be	 necessary	 in	 real	 applications	 requiring	
periodic	 testing,	 such	 as	 in	 food	 quality	 control	 or	
environmental	monitoring.	
This	 research	 represents	 a	 significant	 advancement	 in	
development	 of	 practical	 point-of-care	 photonic	 biosensors,	
providing	 complex	 automated	 fluid	 handling	 capabilities	
compatible	 with	 simple	 and	 scalable	 fabrication	 and	 robust	
integration.	 This	 research	 is	 intended	 to	 reduce	 the	 cost	 and	
effort	 required	 for	 the	 fabrication	 of	 complex	 lab-on-a-chip	
platforms,	while	 increasing	 the	 level	of	 functional	 integration,	
making	 application	 of	 these	 intricate	 devices	 across	 a	 broad	
range	of	research	fields	more	practical.	In	addition,	a	sufficient	
reduction	 in	 fabrication	 complexity	 is	 intended	 to	 enable	 a	
higher	 level	 of	 fluidic	 control	 sophistication	 in	 point-of-care	
medical	 diagnostic	 devices,	 allowing	 use	 of	 more	 complex	
biosensors.	 This	 research	 could	 potentially	 be	 integrated	 into	
commercial	large	scale	fabrication	of	point-of-care	devices.		
The	 automated	 nature	 of	 this	 system	 makes	 it	 suited	 to	
performing	 repetitive	 assay	 cycles	 which	 could	 be	 used	 to	
sweep	 parameters	 in	 order	 to	 optimise	 surface	 chemistry.	
Future	 work	 will	 include	 optimising	 the	 biolayer	 and	
regeneration	 protocol,	 with	 the	 intention	 of	 providing	 more	
stable	 biosensors	 and	 increasing	 sensor	 lifetime.	 Further	
expansion	of	the	system	is	intended	to	allow	for	multiplexing	of	
multiple	 biosensors,	 as	 well	 as	 the	 addition	 of	 sample	
preparation	 subsystems,	 providing	 additional	 functionality	
critical	to	point-of-care	applications.	
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superimposed	reference	and	competitive	assay.	The	presence	of	tetracycline	in	the	sample	leads	to	an	inhibition	of	the	sensor	response.	Fig.6B	shows	the	sensor	response	for	14	
sequential	measurement-regeneration	cycles,	alternating	reference	sample	(free	of	antibiotic)	and	spiked	sample	(2	nM	tetracycline).	Fig.6C	shows	normalised	results	with	each	
competitive	assay	as	a	percentage	of	its	corresponding	reference	cycle.	
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Supplementary	Material	SM-1:	Experimental	setup	
Operation	 of	 the	 Bimodal	 waveguide	 biosensor	 was	 conducted	 using	 an	 experimental	 setup	 similar	 to	
previously	outlined	1.	A	He-Ne	laser	(632.8nm,	10	mW)	was	end-fire	coupled	to	the	biosensor	through	a	40x	
microscope	objective	 using	TE	polarization,	 the	 resultant	 interferometric	 signal	was	acquired	with	 a	duel	
segment	photodiode	(S5870,	Hamamtsu)	and	data	analysis	was	performed	using	LabVIEW	software	(National	
Instruments,	USA).	The	microfluidic	module	was	clamped	 to	 the	BiMW	sensor	directly	between	a	PMMA	
clamp	and	a	thermal	regulation	stage,	stabilising	intrinsic	signal	drift	due	to	environmental	thermal	influence	
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Supplementary	Fig.S-1:	On	chip	diaphragm	pump	geometry	
	
Supplementary	Fig.S-1:	On	chip	diaphragm	pump	geometry.	Fig.S-1	A	shows	a	dissected	segment	of	the	
microfluidic	module,	showing	the	various	critical	components,	and	illustrating	their	relative	size.	A	dashed	
line	 through	 the	pump	 chamber	shows	a	cut,	with	Fig.S-1	B	 showing	a	cross	 sectional	 image	of	 this	 cut	
surface,	illustrating	the	relative	thickness	of	primary,	membrane,	and	actuation	chamber	components	of	the	
valves	used	in	this	module.	
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Supplementary	Fig.S-2:	Raw	sensor	data	
Supplementary	 Fig.S-2:	 Raw	 sensor	 data	 for	 reference	 and	
competitive	assay	pairs.	sensor	signal	and	extrapolated	signal	in	π	
rad	are	shown	in	red	at	the	top	of	each	graph	
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